DNAJC14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.815800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.446000E-01
Normal-vs-Stage2
3.971600E-01
Normal-vs-Stage3
5.908500E-02
Normal-vs-Stage4
8.751000E-01
Stage1-vs-Stage2
1.290400E-02
Stage1-vs-Stage3
2.996300E-02
Stage1-vs-Stage4
4.480800E-01
Stage2-vs-Stage3
3.244000E-02
Stage2-vs-Stage4
4.875200E-01
Stage3-vs-Stage4
1.183150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.224000E-01
Normal-vs-AfricanAmerican
3.506000E-01
Normal-vs-Asian
1.555620E-01
Caucasian-vs-AfricanAmerican
6.936200E-01
Caucasian-vs-Asian
1.030620E-01
AfricanAmerican-vs-Asian
4.007200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.770800E-01
Normal-vs-Female
5.942400E-01
Male-vs-Female
7.260800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.130600E-01
Normal-vs-Age(41-60Yrs)
9.580400E-01
Normal-vs-Age(61-80Yrs)
4.506600E-01
Normal-vs-Age(81-100Yrs)
1.714790E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.164000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.319700E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.139000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.084100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.079900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.587400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.490970E-01
Normal-vs-Daily Drinker
2.658600E-01
Normal-vs-Weekly Drinker
2.300400E-01
Normal-vs-Occasional Drinker
7.908800E-01
Normal-vs-Social Drinker
6.408200E-01
Non Drinker-vs-Daily Drinker
6.345000E-01
Non Drinker-vs-Weekly Drinker
9.325600E-01
Non Drinker-vs-Occasional Drinker
2.436200E-03
Non Drinker-vs-Social Drinker
7.336100E-02
Daily Drinker-vs-Weekly Drinker
6.628000E-01
Daily Drinker-vs-Occasional Drinker
1.673990E-02
Daily Drinker-vs-Social Drinker
2.156000E-01
Weekly Drinker-vs-Occasional Drinker
1.934190E-02
Weekly Drinker-vs-Social Drinker
1.455160E-01
Occasional Drinker-vs-Social Drinker
2.319200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.921590E-01
Normal-vs-Grade 2
1.930390E-02
Normal-vs-Grade 3
2.170400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.071400E-01
Grade 1-vs-Grade 3
7.398400E-01
Grade 1-vs-Grade 4
1.921590E-01
Grade 2-vs-Grade 3
2.918000E-01
Grade 2-vs-Grade 4
1.930390E-02
Grade 3-vs-Grade 4
2.170400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.620600E-01
Normal-vs-NonDiabetic
6.128200E-01
Diabetic-vs-NonDiabetic
2.688800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.645400E-01
Normal-vs-NoPancreatitis
5.743400E-01
Pancreatitis-vs-NoPancreatitis
9.297000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.091600E-01
Normal-vs-N1
4.363800E-01
N0-vs-N1
6.196000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.437800E-01
Normal-vs-TP53-NonMutant
8.769600E-01
TP53-Mutant-vs-TP53-NonMutant
5.356000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
